Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Breast Cancer Update 2014 - Focus on the Patient and the Tumour.

Maass N, Schütz F, Fasching PA, Fehm T, Janni W, Kümmel S, Kolberg HC, Lüftner D, Wallwiener M, Lux MP.

Geburtshilfe Frauenheilkd. 2015 Feb;75(2):170-182.

2.

Comparison of Sonography versus Digital Breast Tomosynthesis to Locate Intramammary Marker Clips.

Schulz-Wendtland R, Dankerl P, Dilbat G, Bani M, Fasching PA, Heusinger K, Lux MP, Loehberg CR, Jud SM, Rauh C, Bayer CM, Beckmann MW, Wachter DL, Uder M, Meier-Meitinger M, Brehm B.

Geburtshilfe Frauenheilkd. 2015 Jan;75(1):72-76.

3.

Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network.

Fasching PA, Brucker SY, Fehm TN, Overkamp F, Janni W, Wallwiener M, Hadji P, Belleville E, Häberle L, Taran FA, Lüftner D, Lux MP, Ettl J, Müller V, Tesch H, Wallwiener D, Schneeweiss A.

Geburtshilfe Frauenheilkd. 2015 Jan;75(1):41-50.

4.

Association of molecular subtypes with breast cancer risk factors: a case-only analysis.

Rauh C, Gass P, Heusinger K, Haeberle L, Jud SM, Hein A, Loehberg CR, Lux MP, Wachter DL, Heimrich J, Strehl JD, Haller F, Hartmann A, Schulz-Wendtland R, Fiessler C, Beckmann MW, Fasching PA, Poehls U.

Eur J Cancer Prev. 2014 Dec 9. [Epub ahead of print]

PMID:
25494290
5.

Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients.

Blank PR, Filipits M, Dubsky P, Gutzwiller F, Lux MP, Brase JC, Weber KE, Rudas M, Greil R, Loibl S, Szucs TD, Kronenwett R, Schwenkglenks M, Gnant M.

Pharmacoeconomics. 2015 Feb;33(2):179-90. doi: 10.1007/s40273-014-0227-x.

6.

Establishment of the Certification System "Gynaecological Dysplasia" in Germany.

Beckmann MW, Quaas J, Bischofberger A, Kämmerle A, Lux MP, Wesselmann S.

Geburtshilfe Frauenheilkd. 2014 Sep;74(9):860-867.

7.

Time and Resources Needed to Document Patients with Breast Cancer from Primary Diagnosis to Follow-up - Results of a Single-center Study.

Lux MP, Sell CS, Fasching PA, Seidl-Ertel J, Bani MR, Schrauder MG, Jud SM, Loehberg CR, Rauh C, Hartmann A, Schulz-Wendtland R, Strnad V, Beckmann MW.

Geburtshilfe Frauenheilkd. 2014 Aug;74(8):743-751.

8.

Best supportive care from the conservative/non-surgical perspective and its costs in the treatment of patients with advanced medullary thyroid cancer: results of a Delphi panel.

Kreissl MC, Jacob C, Führer D, Karges W, Luster M, Lux MP, Mann K, Mittendorf T, Schott M, Spitzweg C, Schmoll HJ.

Oncol Res Treat. 2014;37(6):316-22. doi: 10.1159/000362613. Epub 2014 May 12.

PMID:
24903762
9.

Impact of Patient and Procedure Mix on Finances of Perinatal Centres - Theoretical Models for Economic Strategies in Perinatal Centres.

Hildebrandt T, Kraml F, Wagner S, Hack CC, Thiel FC, Kehl S, Winkler M, Frobenius W, Faschingbauer F, Beckmann MW, Lux MP.

Geburtshilfe Frauenheilkd. 2013 Aug;73(8):783-791.

10.

Full Field Digital Mammography (FFDM) versus CMOS Technology, Specimen Radiography System (SRS) and Tomosynthesis (DBT) - Which System Can Optimise Surgical Therapy?

Schulz-Wendtland R, Dilbat G, Bani M, Fasching PA, Heusinger K, Lux MP, Loehberg CR, Brehm B, Hammon M, Saake M, Dankerl P, Jud SM, Rauh C, Bayer CM, Beckmann MW, Uder M, Meier-Meitinger M.

Geburtshilfe Frauenheilkd. 2013 May;73(5):422-427.

11.

Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis.

Fasching PA, Ekici AB, Wachter DL, Hein A, Bayer CM, Häberle L, Loehberg CR, Schneider M, Jud SM, Heusinger K, Rübner M, Rauh C, Bani MR, Lux MP, Schulz-Wendtland R, Hartmann A, Beckmann MW.

Geburtshilfe Frauenheilkd. 2013 Dec;73(12):1228-1235.

12.

Evaluation of Newly Adapted Clip Marker System in Ultrasound-Guided Core Needle Biopsy for Suspicion of Breast Cancer.

Schulz-Wendtland R, Dankerl P, Dilbat G, Bani M, Fasching PA, Heusinger K, Lux MP, Loehberg CR, Jud SM, Rauh C, Bayer CM, Beckmann MW, Uder M, Meier-Meitinger M, Brehm B.

Geburtshilfe Frauenheilkd. 2013 Nov;73(11):1135-1138.

13.

Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patients.

Hein A, Bayer CM, Schrauder MG, Häberle L, Heusinger K, Strick R, Ruebner M, Lux MP, Renner SP, Schulz-Wendtland R, Ekici AB, Hartmann A, Beckmann MW, Fasching PA.

Biomed Res Int. 2014;2014:842452. doi: 10.1155/2014/842452. Epub 2014 Mar 5.

14.

Economic constraints - the growing challenge for Western breast cancer centers.

Seidel RP, Lux MP, Hoellthaler J, Beckmann MW, Voigt W.

Breast Care (Basel). 2013 Mar;8(1):41-7. doi: 10.1159/000348356. Review.

15.

Health economics in breast cancer.

Beckmann MW, Lux MP.

Breast Care (Basel). 2013 Mar;8(1):5-6. doi: 10.1159/000346882. No abstract available.

16.

Health utilities in gynecological oncology and mastology in Germany.

Hildebrandt T, Thiel FC, Fasching PA, Graf C, Bani MR, Loehberg CR, Schrauder MG, Jud SM, Hack CC, Beckmann MW, Lux MP.

Anticancer Res. 2014 Feb;34(2):829-35.

PMID:
24511019
17.

FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients.

Fasching PA, Jud SM, Hauschild M, Kümmel S, Schütte M, Warm M, Hanf V, Grab D, Krocker J, Stickeler E, Kreienberg R, Müller T, Kühn T, Wolf C, Kahlert S, Paepke S, Berghorn M, Muth M, Baier M, Wackwitz B, Schulz-Wendtland R, Beckmann MW, Lux MP.

BMC Cancer. 2014 Feb 5;14:66. doi: 10.1186/1471-2407-14-66.

18.

Comprehensive visualization of paresthesia in breast cancer survivors.

Jud SM, Hatko R, Maihöfner C, Bani MR, Schrauder MG, Lux MP, Beckmann MW, Bani G, Eder I, Fasching PA, Loehberg CR, Rauh C, Hein A.

Arch Gynecol Obstet. 2014 Jul;290(1):135-41. doi: 10.1007/s00404-014-3164-1. Epub 2014 Feb 5.

PMID:
24496514
19.

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.

Purrington KS, Slager S, Eccles D, Yannoukakos D, Fasching PA, Miron P, Carpenter J, Chang-Claude J, Martin NG, Montgomery GW, Kristensen V, Anton-Culver H, Goodfellow P, Tapper WJ, Rafiq S, Gerty SM, Durcan L, Konstantopoulou I, Fostira F, Vratimos A, Apostolou P, Konstanta I, Kotoula V, Lakis S, Dimopoulos MA, Skarlos D, Pectasides D, Fountzilas G, Beckmann MW, Hein A, Ruebner M, Ekici AB, Hartmann A, Schulz-Wendtland R, Renner SP, Janni W, Rack B, Scholz C, Neugebauer J, Andergassen U, Lux MP, Haeberle L, Clarke C, Pathmanathan N, Rudolph A, Flesch-Janys D, Nickels S, Olson JE, Ingle JN, Olswold C, Slettedahl S, Eckel-Passow JE, Anderson SK, Visscher DW, Cafourek VL, Sicotte H, Prodduturi N, Weiderpass E, Bernstein L, Ziogas A, Ivanovich J, Giles GG, Baglietto L, Southey M, Kosma VM, Fischer HP; GENICA Network, Reed MW, Cross SS, Deming-Halverson S, Shrubsole M, Cai Q, Shu XO, Daly M, Weaver J, Ross E, Klemp J, Sharma P, Torres D, Rüdiger T, Wölfing H, Ulmer HU, Försti A, Khoury T, Kumar S, Pilarski R, Shapiro CL, Greco D, Heikkilä P, Aittomäki K, Blomqvist C, Irwanto A, Liu J, Pankratz VS, Wang X, Severi G, Mannermaa A, Easton D, Hall P, Brauch H, Cox A, Zheng W, Godwin AK, Hamann U, Ambrosone C, Toland AE, Nevanlinna H, Vachon CM, Couch FJ.

Carcinogenesis. 2014 May;35(5):1012-9. doi: 10.1093/carcin/bgt404. Epub 2013 Dec 9.

20.

Financial viability of perinatal centers in the longer term, taking legislative requirements into account. An examination of the cost-revenue structure of a Level I perinatal center.

Lux MP, Kraml F, Wagner S, Hack CC, Schulze C, Faschingbauer F, Winkler M, Fasching PA, Beckmann MW, Hildebrandt T.

In Vivo. 2013 Nov-Dec;27(6):855-67.

PMID:
24292593
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk